COVID-19 and emerging viral infections: The case for interferon lambda.
J Exp Med
; 217(5)2020 05 04.
Article
em En
| MEDLINE
| ID: mdl-32289152
ABSTRACT
With the first reports on coronavirus disease 2019 (COVID-19), which is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the scientific community working in the field of type III IFNs (IFN-λ) realized that this class of IFNs could play an important role in this and other emerging viral infections. In this Viewpoint, we present our opinion on the benefits and potential limitations of using IFN-λ to prevent, limit, and treat these dangerous viral infections.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pneumonia Viral
/
Interferons
/
Infecções por Coronavirus
/
Betacoronavirus
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article